 | | Vol. 17.32 – 16 August, 2023 |
| |
|
|
| Researchers analyzed the intratumoral blood-brain-tumor barrier heterogeneity in human glioblastoma and characterized two genetically engineered models in female mice that recapitulated two important glioma phenotypes.
[Nature Communications] |
|  |
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors identified the therapeutic target NF-E2-related factor 2 (Nrf2) that modulated neuroinflammation-triggered reactive astrocyte conversion.
[Proceedings Of The National Academy Of Sciences Of The United States Of America] |
|
|
|
| Investigators demonstrated the functional importance of cell adhesion molecule-downregulated oncogene (Cdon) in motor neuron function and nerve repair.
[Journal Of Cachexia Sarcopenia And Muscle] |
|
|
|
| Scientists investigated the distribution and functional relevance of fibroblast growth factor receptor 1 (FGFR1) and FGFR2 in human glioblastoma xenograft models.
[Cancer Letters] |
|
|
|
| Researchers showed that US28 increased the malignancy of U251 glioblastoma cells by enhancing signaling mediated by sphingosine-1-phosphate (S1P), a bioactive lipid that stimulated oncogenic pathways in glioblastoma.
[Science Signaling] |
|
|
|
| Investigators employed Neuronal Differentiation 4 (NeuroD4), a crucial transcription factor in neuronal development, to reprogram glioblastoma cells into neuron-like cells.
[Cell Death Discovery] |
|
|
|
| Researchers demonstrated that a new class of asymmetric, charge balanced waveforms were effective at directing retinal ganglion cell axon growth, in vitro, without compromising cell viability.
[Scientific Reports] |
|
|
|
| The authors investigated the biological functions of stromal interactive molecule 2 (STIM2) and its related mechanisms in cerebral ischemia/reperfusion injury progression.
[Molecular Biotechnology] |
|
|
|
| Scientists defined the role of polo-like kinase 3 (PLK3)-dependent proneural–mesenchymal transition in glioblastoma therapy.
[Molecular Biology Reports] |
|
|
|
|
| The authors explore the exosome–glioblastoma (GBM) interlink, the clinical impact of exosomes on GBM biomarkers, the therapeutics signature of exosomes in GBM, exosome-based research challenges, and future directions in GBM.
[ACS Biomaterials Science & Engineering] |
|
|
|
|
| The Robert H. Lurie Comprehensive Cancer Center of Northwestern University has received a renewed $10.8 million Specialized Program of Research Excellence (SPORE) grant to advance translational research and improve outcomes for patients with brain cancer.
[Northwestern University] |
|
|
|
|
| October 1 – 4, 2023
Whistler, British Columbia, Canada |
|
|
|
|
|
| | Van Andel Institute – Grand Rapids, Michigan, United States |
|
|
|
| | Creative Biolabs – New York, New York, United States |
|
|
|
| | Center for Excellence in Molecular Cell Science – Shanghai, China |
|
|
|
| | Weill Cornell – New York, New York, United States |
|
|
|
| | Cedars-Sinai – Los Angeles, California, United States |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
